Five genes (KIF5C, LINC00632, B4GALNT3, HIF3A, and RAD51L3-RFFL) show significant differential expression between primary and recurrent tumors, with four having established functional roles in glioma pathobiology. This evidence concerns the gene KIF5C and central nervous system cancer.